Commonwealth Equity Services
CNTB

Commonwealth Equity Services’s Connect Biopharma Holdings CNTB Stock Holding History

Commonwealth Equity Services’s Portfolio CNTB Stock Details CNTB Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2025
Q3 		– Sell
-20,000
Closed -$20K – 4270
2025
Q2 		$20K Hold
20,000
– – ﹤0.01% 4215
2025
Q1 		$11K Hold
20,000
– – ﹤0.01% 4145
2024
Q4 		$28K Hold
20,000
– – ﹤0.01% 4022
2024
Q3 		$29K Hold
20,000
– – ﹤0.01% 3979
2024
Q2 		$30K Hold
20,000
– – ﹤0.01% 3937
2024
Q1 		$35K Buy
+20,000
New +$24.3K ﹤0.01% 3927

Other funds holding CNTB

BCM
BML Capital Management Zionsville, Indiana $156M AUM 129.82% 1-Year Est. Return
Renaissance Technologies
Renaissance Technologies New York $63.9B AUM 45.56% 1-Year Est. Return
Marshall Wace
Marshall Wace London, United Kingdom $100B AUM 35.1% 1-Year Est. Return
KWM
Koa Wealth Management Encinitas, California $138M AUM 13.03% 1-Year Est. Return
XT
XTX Topco George Town, Cayman Islands $5.75B AUM 30.56% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
Susquehanna International Group
Susquehanna International Group Bala Cynwyd, Pennsylvania $893B AUM 36.07% 1-Year Est. Return
MWA
Monograph Wealth Advisors Manhattan Beach, California $1.05B AUM 23.2% 1-Year Est. Return
HF
HRT Financial New York $40.1B AUM 58.22% 1-Year Est. Return
Citigroup
Citigroup New York $235B AUM 32.99% 1-Year Est. Return

Commonwealth Equity Services's CNTB Position: Q3 2025 in Review

Commonwealth Equity Services sold out of Connect Biopharma Holdings (CNTB) in Q3 2025, closing a stake of 20,000 shares — an estimated $20K sold.

Commonwealth Equity Services first reported a position in CNTB in Q1 2024 and held it in 6 quarters. The position peaked at $35K in Q1 2024. 16 funds tracked by Wall St. Rank hold CNTB as of Q3 2025.

  • Commonwealth Equity Services reported no remaining Connect Biopharma Holdings position as of Q3 2025 after selling out during the quarter.
  • Commonwealth Equity Services sold 20,000 Connect Biopharma Holdings shares in Q3 2025, an estimated $20K.
  • Commonwealth Equity Services first reported a position in Connect Biopharma Holdings in Q1 2024 and held it in 6 quarters.
  • Commonwealth Equity Services's Connect Biopharma Holdings position peaked at $35K in Q1 2024.
  • 16 funds tracked by Wall St. Rank held Connect Biopharma Holdings as of Q3 2025.

Based on Commonwealth Equity Services's 13F filing for Q3 2025, filed 22 Oct 2025.